FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

116 hedge funds and large institutions have $893M invested in Fate Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 26 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
+13
Holders Change %
+12.62%
% of All Funds
2.66%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
27
Increased
43
Reduced
26
Closed
14
Calls
$2.77M
Puts
$2.43M
Net Calls
+$335K
Net Calls Change
-$401K

Top Buyers

1
RG
Redmile Group
California
$169M
2
PHS
PFM Health Sciences
California
$24.5M
3
DM
Deerfield Management
New York
$19.1M
4
Fidelity Investments
Fidelity Investments
Massachusetts
$124M
5
Citadel Advisors
Citadel Advisors
Florida
$12.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
$2.59M
2
Franklin Resources
Franklin Resources
California
$87.3M
3
Morgan Stanley
Morgan Stanley
New York
$3.44M
4
6CM
683 Capital Management
New York
$10.6M
5
UBS Group
UBS Group
Switzerland
$494K
Name Holding Trade Value Shares
Change 		Shares
Change %
QSS
126
Quantitative Systematic Strategies
Florida
– -$129K -11,350 Closed
PAM
127
Panagora Asset Management
Massachusetts
– -$71K -6,275 Closed
GT
128
Glenmede Trust
Pennsylvania
– -$39K -3,420 Closed
CG
129
Cutler Group
California
– -$11K -1,000 Closed
PIA
130
Piedmont Investment Advisors
North Carolina
– -$10K -863 Closed
2 3 4 5
6